Efectividad del SURFACEN® en neonatos prematuros con síndrome de dificultad respiratoria / Effectiveness of SURFACEN ® in preterm infant with respiratory distress syndrome
anational descriptive, longitudinal, prospective, post-market monitoring, uncontrolled and multicentered study was designed and conducted during the period from 2007 to 2009. The universe of study consisted of 259 infants with respiratory distress syndrome and less than 37 weeks old gestational age, who were administered SURFACEN®. The primary endpoint for evaluation of the surfactanteffectiveness was neonatal mortality.